REFERENCES
1. Welschmeyer A, Berke GS. An updated review of the epidemiological factors associated with recurrent respiratory papillomatosis [Review]. Laryngoscope Investigative Otolaryngology. 2021 April;6(2):226-233. PubMed PMID: 2010280128.
2. Larson DA, Derkay CS. Epidemiology of recurrent respiratory papillomatosis. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica. 2010 Jun;118(6-7):450-4. doi: 10.1111/j.1600-0463.2010.02619.x. PubMed PMID: 20553527; eng.
3. Woo SH, Chung P-S, Sangjoon L. Treatment of Recurrent Respiratory Papillomatosis Using Laser and Available Adjuvant Therapies. Medical Lasers. 2020 2020;9(2):126-133. doi: 10.25289/ml.2020.9.2.126. PubMed PMID: KJD:ART002662788.
4. Manley C, Hutchinson C, Mahajan A, et al. Treatment of Recurrent Respiratory Papillomatosis: Case Series and Review of Technique. Surgical Technology International-International Developments in Surgery and Surgical Research. 2021 Jun;38. PubMed PMID: WOS:000661729000016.
5. Papaspyrou G, Schick B, Papaspyrou S, et al. Retrospective analysis of laser vs other therapeutic modalities for laryngeal papillomatosis: European multicenter study. Journal of Buon. 2016 Sep-Oct;21(5):1274-1278. PubMed PMID: WOS:000388782200031.
6. Tran MN, Galt L, Bashirzadeh F. Recurrent respiratory papillomatosis: the role of cidofovir. Respirol Case Rep. 2018 Nov;6(8):e00371. doi: 10.1002/rcr2.371. PubMed PMID: 30302253; PubMed Central PMCID: PMCPMC6167758. eng.
7. El-Bitar MA, Zalzal GH. Powered instrumentation in the treatment of recurrent respiratory papillomatosis - An alternative to the carbon dioxide laser. Archives of Otolaryngology-Head & Neck Surgery. 2002 Apr;128(4):425-428. doi: 10.1001/archotol.128.4.425. PubMed PMID: WOS:000174855200013.
8. Murono S, Nakanishi Y, Tsuji A, et al. Trends in the management of recurrent respiratory papillomatosis in Japan. Auris Nasus Larynx. 2015 Jun;42(3):218-220. doi: 10.1016/j.anl.2014.10.006. PubMed PMID: WOS:000355031300007.
9. Papaioannou VA, Lux A, Voigt-Zimmermann S, et al. Treatment outcomes of recurrent respiratory papillomatosis: Retrospective analysis of juvenile and adult cases [Article]. HNO. 2018;66:7-15. doi: 10.1007/s00106-017-0378-0. PubMed Central PMCID: PMC28840259. English.
10. Lawlor C, Balakrishnan K, Bottero S, et al. International Pediatric Otolaryngology Group (IPOG): Juvenile-onset recurrent respiratory papillomatosis consensus recommendations. International Journal of Pediatric Otorhinolaryngology. 2020 Jan;128. doi: 10.1016/j.ijporl.2019.109697. PubMed PMID: WOS:000508742100011.
11. Derkay CS, Hester RP, Burke B, et al. Analysis of a staging assessment system for prediction of surgical interval in recurrent respiratory papillomatosis. International Journal of Pediatric Otorhinolaryngology. 2004 Dec;68(12):1493-1498. doi: 10.1016/j.ijporl.2004.06.007. PubMed PMID: WOS:000225323400002.
12. Patel N, Rowe M, Tunkel D. Treatment of recurrent respiratory papillomatosis in children with the microdebrider. Annals of Otology Rhinology and Laryngology. 2003 Jan;112(1):7-10. doi: 10.1177/000348940311200102. PubMed PMID: WOS:000180442300002.
13. Hung WC, Lo WC, Fang KM, et al. Longitudinal Voice Outcomes Following Serial Potassium Titanyl Phosphate Laser Procedures for Recurrent Respiratory Papillomatosis. The Annals of otology, rhinology, and laryngology. 2021 Apr;130(4):363-369. doi: 10.1177/0003489420950374. PubMed PMID: 32847376; eng.
14. Rees CJ, Tridico TI, Kirse DJ. Expanding applications for the microdebrider in pediatric endoscopic airway surgery. Otolaryngology-Head and Neck Surgery. 2005 Oct;133(4):509-513. doi: 10.1016/j.otohns.2005.06.029. PubMed PMID: WOS:000232461000006.
15. Dedo HH, Yu KCY. CO2 laser treatment in 244 patients with respiratory papillomas. The Laryngoscope. 2001 Sep;111(9):1639-1644. doi: 10.1097/00005537-200109000-00028. PubMed PMID: WOS:000170987500028.
16. Hock K, Kennedy A, Howell R, et al. Surgery and Adjuvant Therapy Improve Derkay Scores in Adult and Pediatric Respiratory Papillomatosis. The Laryngoscope. 2022. doi: 10.1002/lary.30042. PubMed PMID: WOS:000750938400001.
17. Burns JA, Friedman AD, Lutch MJ, et al. Value and utility of 532 nanometre pulsed potassium-titanyl-phosphate laser in endoscopic laryngeal surgery. Journal of Laryngology and Otology. 2010 Apr;124(4):407-411. doi: 10.1017/s0022215109991824. PubMed PMID: WOS:000276923300012.
18. Preuss SF, Klussmann JP, Jungehulsing M, et al. Long-term results of surgical treatment for recurrent respiratory papillomatosis. Acta oto-laryngologica. 2007 Nov;127(11):1196-201. doi: 10.1080/00016480701200350. PubMed PMID: 17851940; eng.
19. Araki K, Tomifuji M, Uno K, et al. Feasibility of transnasal flexible carbon dioxide laser surgery for laryngopharyngeal lesions. Auris Nasus Larynx. 2019 Oct;46(5):772-778. doi: 10.1016/j.anl.2019.01.008. PubMed PMID: 30765273; eng.
20. Miller AJ, Gardner GM. In-Office vs. Operating Room Procedures for Recurrent Respiratory Papillomatosis. Ent-Ear Nose & Throat Journal. 2019 Dec. doi: 10.1177/0145561319889538. PubMed PMID: WOS:000680807300001.